Who Treats High Cholesterol? PCP, Cardiologist, or Lipidologist
Most high cholesterol is treated by your primary care doctor. Here's when a cardiologist, lipidologist, or endocrinologist makes sense — and how to find one.
Manifold Health Clinical Team
Medically reviewed clinical content
Table of contents
Share
For most people, high cholesterol is treated by a primary care physician — they order the lipid panel, assess your overall cardiovascular risk, and prescribe first-line treatment like statins.
A specialist enters the picture when the numbers are unusually high, cholesterol runs strongly in your family, treatment isn't working or isn't tolerated, or you already have heart disease. In those situations, the right referral is usually a cardiologist (often one focused on prevention), a lipidologist (a physician with advanced training in cholesterol and lipid disorders), or sometimes an endocrinologist. This guide explains what each one does, the specific situations where clinicians generally recommend a referral, and how to find the right fit.
The short version
Start with primary care. Routine high cholesterol — the kind found on a screening lipid panel — is squarely within a primary care physician's wheelhouse, including prescribing statins and other first-line medications.
A cardiologist makes sense when heart disease is present or likely. If you've had a heart attack, stent, stroke, or a high coronary artery calcium score — or your risk is high and rising — cardiology adds value. Preventive cardiologists focus specifically on stopping heart disease before it happens.
A lipidologist is the cholesterol super-specialist. These are physicians (often cardiologists, endocrinologists, or internists) with additional certification in complex lipid disorders — severe or inherited high cholesterol, very high triglycerides, statin intolerance, and high Lp(a).
Inherited high cholesterol changes the calculus. Familial hypercholesterolemia (FH) affects roughly 1 in 250 people, most of them undiagnosed. Guidance from the National Lipid Association suggests specialist referral is prudent unless your physician has specific expertise managing it.
The 2026 guideline created new "who do I see?" moments. The new ACC/AHA multisociety dyslipidemia guideline recommends every adult have Lp(a) measured at least once — which means more people discovering an elevated result and wondering what kind of doctor handles it.
This is educational information to help you navigate care, not medical advice. It doesn't diagnose any condition or tell you what treatment you need — a qualified clinician does that for your specific situation.
Can my primary care doctor treat high cholesterol?
Yes — and for most people, that's exactly who should. High cholesterol is one of the most common findings in primary care, and the playbook is well established: a lipid panel, a 10-year cardiovascular risk estimate, lifestyle counseling, and — when risk warrants it — medication, most often a statin. Your primary care physician can also order follow-up testing, adjust doses, and monitor for side effects.
Primary care is also where the screening that finds high cholesterol in the first place happens. If you haven't had a lipid panel recently, that's a primary care conversation — not a specialist one. And if you're not sure what your results mean, a marker like ApoB — which the 2026 guideline highlights as a useful risk refinement in specific situations — is something a good primary care clinician can interpret with you.
Where primary care reaches its limits is complexity: numbers that suggest a genetic condition, treatment that isn't reaching goals, side effects that keep interrupting therapy, or unusual patterns like very high triglycerides. That's when the referral question gets real.
When should you see a specialist for high cholesterol?
There's no single rule, but clinicians generally consider specialist referral in a recognizable set of situations. Think of this as a checklist to bring to your primary care visit — not a diagnosis.
Clinicians generally recommend seeing a specialist if:
Your LDL cholesterol is 190 mg/dL or higher. Levels this high raise the possibility of familial hypercholesterolemia, an inherited condition that standard risk calculators underestimate.
High cholesterol or early heart disease runs in your family. A parent or sibling with a heart attack or stroke at a young age (before ~55 in men, ~65 in women) is a signal worth specialist attention.
You've been diagnosed with — or screened positive for — familial hypercholesterolemia. The National Lipid Association's updated consensus notes that referral to a cardiologist or lipidologist specializing in prevention is prudent unless your physician has specific FH expertise.
Your Lp(a) is significantly elevated. Lp(a) is largely genetic, doesn't respond meaningfully to lifestyle change, and at higher levels is associated with substantially increased cardiovascular risk. Specialists are more likely to be current on emerging Lp(a)-targeted therapies and trials.
You can't tolerate statins. True statin intolerance is a solvable problem more often than people think, but solving it — alternate dosing, different agents, non-statin options — is a specialist's daily work.
You're not reaching treatment goals. If you're on maximally tolerated therapy and LDL remains well above target, additional options exist, and a specialist can sequence them.
You already have cardiovascular disease. After a heart attack, stent, bypass, or stroke, lipid management is part of cardiology care, and treatment targets are more aggressive.
Your triglycerides are very high (generally 500 mg/dL or above), which carries its own risks and its own treatment pathway — often involving an endocrinologist or lipidologist.
One reason referral matters in severe cases: research published in the Journal of the American Heart Association found that patients with severe hypercholesterolemia who had cardiology-clinic involvement were significantly more likely to receive evidence-based lipid-lowering therapy than those managed without it.
Who actually treats high cholesterol? The four provider types
The names overlap more than you'd expect — many lipidologists are cardiologists, and many preventive cardiologists function as lipid specialists. Here's how the roles differ in practice.
This table compares the four provider types you're most likely to encounter.
Provider | Who they are | Best fit when |
|---|---|---|
Primary care physician | Family medicine or internal medicine; your front door to care | Routine screening and treatment; most high cholesterol |
Cardiologist | Heart specialist; diagnoses and treats cardiovascular disease | Existing heart disease, abnormal cardiac testing, high or rising risk |
Preventive cardiologist | Cardiologist focused on stopping heart disease before events happen | Strong family history, high Lp(a), high calcium score, risk optimization |
Lipidologist | Physician with advanced certification in lipid disorders (via the American Board of Clinical Lipidology / National Lipid Association pathway) | FH, severe or treatment-resistant cholesterol, statin intolerance, very high triglycerides |
The plain-language takeaway: primary care treats the condition; cardiology treats the disease it causes; a lipidologist treats the hard cases of the condition itself. An endocrinologist — a hormone and metabolism specialist — is a fifth player who often manages lipids when diabetes, thyroid disease, or metabolic syndrome is part of the picture, since those conditions directly affect cholesterol. (More on that in what an endocrinologist does.)
What is a lipidologist, exactly?
A lipidologist is not a separate residency-trained specialty like cardiology. It's a physician — usually a cardiologist, endocrinologist, or internist — who has completed additional training and certification in clinical lipidology. They focus entirely on disorders of cholesterol and other blood fats: familial hypercholesterolemia, elevated Lp(a), severe hypertriglyceridemia, and patients who've run out of standard options. Because the field is small, lipidologists are concentrated in academic centers and dedicated lipid clinics — and telehealth has made them far more reachable than they used to be (see telehealth vs. in-person care).
Preventive cardiologist vs. general cardiologist
A general cardiologist spends much of their time on diagnosed disease — imaging, catheterization, arrhythmias, heart failure. A preventive cardiologist works upstream: aggressive risk assessment (including coronary artery calcium scoring, ApoB, and Lp(a)), lipid management, blood pressure, and metabolic health, with the goal of making sure the first cardiac event never happens. If you don't have heart disease but your risk factors are stacking up, "preventive cardiology" is often the more precise search term.
Why 2026 changed this question
Two developments made "who do I see for cholesterol?" a more common — and more consequential — question this year.
Universal Lp(a) testing. The 2026 ACC/AHA multisociety dyslipidemia guideline recommends, for the first time in a U.S. guideline, that every adult have lipoprotein(a) measured at least once. Lp(a) is mostly genetic and barely budges with lifestyle change, so an elevated result naturally raises the navigation question: now what, and with whom? For significantly elevated levels, that conversation increasingly involves a preventive cardiologist or lipidologist.
The first oral PCSK9 inhibitor. In July 2026, the FDA approved enlicitide (brand name Lipfendra), the first once-daily pill in the PCSK9-inhibitor class — a class that until now required injections. It's approved as an add-on to diet and statin therapy for adults with high LDL, including heterozygous familial hypercholesterolemia. What matters for navigation: the treatment landscape for hard-to-control cholesterol has more options than it did a year ago, and whether any of them fits your situation is a determination a clinician makes — often a specialist, since these therapies typically follow first-line treatment. If you've read a headline and wondered "who would even prescribe this?", the answer is usually a cardiologist, lipidologist, or a primary care physician comfortable with advanced lipid therapy.
How to find the right cholesterol specialist
A few practical routes, in the order most people should try them:
Ask your primary care physician directly. "Do you think my situation needs a lipid specialist, or are you comfortable managing it?" is a fair and useful question. Good PCPs refer readily when complexity warrants it.
Search by the right term. For prevention-focused care, search "preventive cardiology" rather than just "cardiologist." For complex or inherited cholesterol, search "lipid clinic" or "lipidologist" — academic medical centers near you are the most reliable bet.
Check your coverage before booking. Specialist visits are where surprise costs show up. Our guide to finding a doctor who takes your insurance walks through verifying network status the right way.
Consider telehealth for lipid care. Lipid management is largely conversation, labs, and medication adjustment — which makes it one of the better-suited specialties for virtual visits, especially if no lipid clinic operates near you.
Bring your numbers. Your most recent lipid panel, any Lp(a) or ApoB results, your medication history (including any statin side effects), and what you know of your family history. Specialists can do far more with a complete picture.
If you're earlier in the process — you know something's off but not which direction to go — our guide to which doctor you actually need maps the full specialty landscape, and Sidewalk can help you narrow it to the right provider type for your situation.
Frequently asked questions
Who treats high cholesterol?
Primary care physicians treat most high cholesterol, including prescribing statins and monitoring results. Specialists — cardiologists, preventive cardiologists, lipidologists, and sometimes endocrinologists — handle cases involving existing heart disease, suspected familial hypercholesterolemia, high Lp(a), statin intolerance, or cholesterol that stays high despite treatment.
When should I see a cardiologist for high cholesterol?
A cardiologist is generally recommended when high cholesterol comes with existing cardiovascular disease (heart attack, stent, stroke), abnormal cardiac testing such as a high coronary artery calcium score, or high overall risk that isn't improving with first-line treatment. For people without heart disease who want aggressive risk reduction, a preventive cardiologist is often the better-matched search term.
What is a lipidologist and how is it different from a cardiologist?
A lipidologist is a physician — often a cardiologist, endocrinologist, or internist by training — with additional certification in clinical lipidology, the medicine of cholesterol and blood-fat disorders. A cardiologist treats the heart broadly; a lipidologist focuses narrowly on complex lipid problems like familial hypercholesterolemia, severe hypertriglyceridemia, statin intolerance, and elevated Lp(a).
What kind of doctor should I see for high Lp(a)?
Start by discussing the result with your primary care physician, who can put it in the context of your overall risk. For significantly elevated Lp(a) — particularly with a family history of early heart disease — clinicians often involve a preventive cardiologist or lipidologist, who are most likely to be current on risk management and emerging Lp(a)-directed therapies. The 2026 ACC/AHA guideline recommends all adults have Lp(a) measured at least once.
Do I need a specialist for familial hypercholesterolemia?
Often, yes. FH affects about 1 in 250 people, most undiagnosed, and untreated it carries a substantially elevated risk of early heart disease — risk that treatment can largely normalize. The National Lipid Association's updated consensus advises that referral to a cardiologist or lipidologist specializing in prevention is prudent unless your physician has specific expertise managing FH. Family members may also benefit from screening, which a specialist can coordinate.
Is high cholesterol ever an emergency?
High cholesterol itself develops silently over years and is not an emergency. But the conditions it contributes to can be: if you experience chest pain or pressure, shortness of breath, sudden weakness or numbness, facial drooping, or trouble speaking, call 911 immediately — do not wait for a cholesterol appointment.
Key takeaways
Your primary care physician is the right starting point — and often the finishing point — for high cholesterol.
Specialist referral makes sense for LDL ≥190 mg/dL, strong family history, suspected or confirmed FH, high Lp(a), statin intolerance, very high triglycerides, missed treatment goals, or existing heart disease.
Lipidologists are the deepest cholesterol specialists; preventive cardiologists focus on stopping heart disease before it starts; endocrinologists fit when diabetes or hormonal conditions drive the picture.
The 2026 dyslipidemia guideline (universal Lp(a) testing) and the July 2026 approval of the first oral PCSK9 inhibitor both expanded what specialists can do — and made knowing who to see more valuable.
Bring your complete numbers and history to any specialist visit; verify network coverage before you book.
Not sure which provider type fits your situation? Sidewalk helps you understand your results and connect with the right care — from primary care to preventive cardiology and lipid specialists. Find the right provider with Sidewalk.
This content is for education and is not medical advice. It does not diagnose, treat, or replace care from a qualified professional. Consult your clinician about your specific situation.
References
American College of Cardiology / American Heart Association et al. 2026 Multisociety Guideline on the Management of Dyslipidemia. Circulation, 2026.
American College of Cardiology. Lower Sooner: How the 2026 Dyslipidemia Guideline Changes Practice. July 2026.
National Lipid Association. Update on Familial Hypercholesterolemia: An Expert Clinical Consensus. Journal of Clinical Lipidology, 2026.
CDC Office of Genomics and Precision Public Health. How Common is Familial Hypercholesterolemia?
American College of Cardiology. Familial Hypercholesterolemia: Cardiovascular Risk Stratification and Clinical Management. 2020.
Merck. FDA Approves LIPFENDRA (enlicitide), the First Once-Daily Oral PCSK9 Inhibitor. July 16, 2026.
TCTMD. FDA Approves Enlicitide, an Oral PCSK9 Inhibitor, for LDL-Lowering. July 2026.
Journal of the American Heart Association. Care of patients with severe hypercholesterolemia — association of cardiology clinic involvement with evidence-based lipid-lowering therapy.
Medical review: Pending — Manifold Health Clinical Team review before publish.
